A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)

Clinical trial NCT04393883 · UNKNOWN

Trial details

NCT number: NCT04393883
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Non-small-lung-cell Cancer, NSCLC Pembrolizumab

Start date: 2021-04-01
Primary completion: 2022-07-01
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.